ACNE TREATMENT Treat 2 g/100mL Gel, 30 mL
by Bio Clarity LLC · 30 mL in 1 TUBE (87799-999-10)
NDC 87799-0999-10
🏷️ FDA NDC (as labeled)
87799-999-10
billing pads the product segment with a zero
This package
Contains30 mL
Pack sizes2 compare ↓
Also comes in:
52 ml 87799-0999-11
OTC
On market
Non-controlled
🗂️ Data synced Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →
🆔 Identity & classification
FDA NDC (as labeled)
87799-999-10
Product NDC
87799-999
11-digit billing NDC
87799099910
RxCUI
346298
UNII
O414PZ4LPZ
Application #
M006
SPL Set ID
4a7e40c1-7421-a0c7-e063-6294a90a4d6b
DEA schedule
Non-controlled
Marketing category
OTC MONOGRAPH DRUG
Marketing status
On market
FDA listing status
Listed (active directory)
Marketing start
2026-02-19
Route
TOPICAL
Dosage form
GEL
Substance
SALICYLIC ACID
Why two NDCs?
The FDA registers this code as 87799-999-10 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 87799-0999-10. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.
🏷️ RxNorm drug class
This medicine belongs to the Salicylic acid and derivatives class.
Drug family (ATC)
Salicylic acid and derivatives, Other antifungals for topical use, Antiinflammatory agents, non-steroids
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.
🏭 Manufacturer & labeler
LabelerBio Clarity LLC
FDA applicationM006 (OTC MONOGRAPH DRUG)
Labeler code87799
First marketedFeb 2026
Product typeHuman Otc Drug
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.
🩺 Clinical
📗 Our plain-language guide HelloPharmacist
- It's designed to treat acne. Salicylic acid helps by loosening and removing dead skin cells that clog pores — the buildup that leads to breakouts. The multi-step system on this lab...
- What is this salicylic acid product actually supposed to do for my skin?
- Some mild tingling, stinging, and peeling is actually expected — that's the salicylic acid doing its job by clearing away dead skin cells. But if the burning or peeling feels exces...
- My skin feels like it's burning and peeling. Is that normal?
Patient education
Supplement & herbal interactions
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.
💬 Questions about Treat?
Ask a pharmacist →
Ask a licensed pharmacist directly — free, answered by our team.
🧪 Inactive Ingredients / Excipients
Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.
Loading inactive ingredients from the official FDA label in the background. No external source is being called by this page request.
Where does this data come from?
Source: official FDA Structured Product Labeling (SPL) via DailyMed and the openFDA label index. Structured
IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.Inactive ingredient FAQ
Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.
💲 Pricing
A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.
| Price system | Per g | Per package |
|---|---|---|
| Retail pharmacies payNADAC · weekly | Not in the retail survey — common for institutional, discontinued, or low-volume packs. | |
| Medicaid paysCMS SDUD · 12 mo | No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data. | |
| Medicare drug plans payPart D · quarterly | No Part D plan price is available for this NDC in our data. | |
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Try another pack size:
52 ml
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.
🔁 Therapeutic equivalents
| Product | Labeler | Pack | NADAC/unit | TE | Status | Price vs. this |
|---|---|---|---|---|---|---|
| Walgreens Acne Control Gel 20 mg/mL 00363-0269-83 | WALGREEN | 1 tube | — | — | FDA listed | — |
| Artistry Studio Done With Zit Acne Treatment Clearing Gel 20 mg/mL 10056-0045-00 | Access | 1 tube | — | — | FDA listed | — |
| Hero Cosmetics Pimple Correct Salicylic Acid Acne Treatment 20 mg/mL 10237-0003-00 | Church | 1 tube | — | — | FDA listed | — |
| Acne Treatment Gel 20 mg/mL 31720-0301-08 | S+ | 1 bottle | — | — | FDA listed | — |
| Eradikate Acne Mark Fading 2 g/100mL 43479-0112-51 | KATE | 1 bottle | — | — | FDA listed | — |
| Clarifying Peel 2 g/100mL 46007-0102-11 | Skin | 20 ml | — | — | Discontinued | — |
| ACNE SolutionS CLINICAL ADVANCED CLEARING gel 20 mg/mL 49527-0221-01 | CLINIQUE | 1 bottle | — | — | Discontinued | — |
| Thayers Since 1847 Natural Remedies Blemish Clearing Witch Hazel Aloe Vera Formula Cleanser 20 mg/mL 49967-0051-01 | L'Oreal | 118 ml | — | — | FDA listed | — |
| CeraVe Developed with Dermatologists Acne Control Acne Treatment 20 mg/mL 49967-0172-01 | L'Oreal | 1 tube | — | — | FDA listed | — |
| Thayers Since 1847 Natural Remedies Blemish Clearing Witch Hazel Aloe Vera Formula Balm 20 mg/mL 49967-0530-01 | L'Oreal | 118 ml | — | — | FDA listed | — |
| Vichy Laboratoires Normaderm Phytoaction Acne Control Daily Moisturizer 20 mg/mL 49967-0606-01 | L'Oreal | 1 bottle | — | — | FDA listed | — |
| Vichy Laboratoires Normaderm Acne Control Daily Moisturizer 20 mg/mL 49967-0660-01 | L'Oreal | 1 bottle | — | — | FDA listed | — |
| clear days ahead fast-acting salicylic acid acne spot treatment .3 g/15mL 50184-1020-01 | Philosophy | 15 ml | — | — | FDA listed | — |
| Dr. Dennis Gross Alpha Beta On the Spot Eliminator 20 mg/mL 51326-0057-01 | Topiderm, | 1 tube | — | — | FDA listed | — |
| GOODBYE ACNE Complete treatment gel .9638 g/48.19g 54031-0069-01 | Peter | 48.19 g | — | — | FDA listed | — |
| BRODA Acne .4 g/20g 54111-0112-50 | Bentley | 20 g | — | — | FDA listed | — |
| XtraCare Deep Cleaning Astringent 5 mg/237mg 57337-0035-01 | Rejoice | 237 mg | — | — | FDA listed | — |
| Acne Defense Spot Treatment Merle Norman 2 g/100g 57627-0201-02 | Merle | 1 tube | — | — | FDA listed | — |
| Image Clear Cell Acne Spot Treatment 20 g/1000g 60232-5022-01 | Swiss-American | 14 g | — | — | FDA listed | — |
| Dry It Out Acne Spot Treatment 2 g/100mL 61197-0122-00 | Pacifica | 29 ml | — | — | FDA listed | — |
| Gm Collin Puracne 20 mg/mL 64127-0195-01 | Laboratoires | 1 tube | — | — | FDA listed | — |
| Overnight Clearing 20 mg/mL 68479-0706-00 | Dermalogica, | 2 ml | — | — | FDA listed | — |
| Milani Erase Base Blemish Control Primer 20 mg/mL 68577-0103-00 | Cosmax | 1 tube | — | — | FDA listed | — |
| PCA SKIN Intensive Clarity Treatment 2 g/100g 68726-0359-02 | CP | 1 tube | — | — | FDA listed | — |
| PCA Gel 2 g/100mL 68726-0445-02 | CP | 1 bottle | — | — | FDA listed | — |
| Spot Stopper Acne Spot Treatment 2 g/100mL 69366-0412-32 | The | 1 tube | — | — | FDA listed | — |
| First Aid Beauty FAB Acne Spot Treatment 2 g/100mL 69423-0724-22 | The | 1 tube | — | — | FDA listed | — |
| Vichy Laboratoires Normaderm Phytoaction Acne Control Moisturizer 20 mg/mL 69625-0605-01 | COSMETIQUE | 1 bottle | — | — | FDA listed | — |
| Vichy Laboratoires Normaderm Acne Control Daily Moisturizer 20 mg/mL 69625-0617-01 | Cosmetique | 1 bottle | — | — | FDA listed | — |
| Vichy Laboratoires Normaderm Acne Control Moisturizer 20 mg/mL 69625-0661-01 | COSMETIQUE | 1 bottle | — | — | FDA listed | — |
| CVS Health Advanced Acne Spot Treatment 20 mg/mL 69842-0464-52 | CVS | 1 tube | — | — | FDA listed | — |
| Neutrogena Rapid Clear Acne Eliminating Spot 20 mg/mL 69968-0472-01 | Kenvue | 1 tube | — | — | FDA listed | — |
| Clean and Clear Acne Spot Treatment 20 mg/mL 69968-0804-01 | Kenvue | 1 tube | — | — | FDA listed | — |
| Neutrogena Rapid Clear Acne Eliminating Spot 20 mg/mL 69968-0825-01 | Kenvue | 1 tube | — | — | FDA listed | — |
| Clean and Clear Acne Spot Treatment 20 mg/g 69968-1016-01 | Kenvue | 1 tube | — | — | FDA listed | — |
| Treat So Deep Acne-Fighting Treatment 2 g/100mL 70626-0106-15 | ASPIRE | 1 tube | — | — | FDA listed | — |
| Acne Treatment Maximum Strength 2 g/100g 70631-0358-02 | Young | 1 tube | — | — | FDA listed | — |
| Acne Spot Treatment 2 g/100mL 70764-0105-51 | CONTROL | 1 bottle | — | — | FDA listed | — |
| innisfree Gentle Retinol Salicylic Acne Serum 1 g/50mL 71220-0088-02 | Innisfree | 1 tube | — | — | FDA listed | — |
| Peace Out Acne Moisturizer 20 mg/mL 71494-0008-01 | Peace | 1 jar | — | — | FDA listed | — |
| Acne Gel Pen 20 mg/mL 71714-0004-01 | Tiege | 1.3 ml | — | — | FDA listed | — |
| Eradikate Acne Mark Fading 2 g/100mL 72204-0903-02 | Rare | 1 bottle | — | — | FDA listed | — |
| ULTA All Clear SERUM 20 mg/g 79959-0011-01 | APR | 1 tube | — | — | FDA listed | — |
| The INKEY List C 50 Serum 20 mg/mL 81136-0020-01 | Brand | 1 bottle | — | — | FDA listed | — |
| The INKEY List Beta Hydroxy Acid Serum 20 mg/mL 81136-0021-01 | Brand | 1 bottle | — | — | FDA listed | — |
| Vichy Laboratoires Normaderm Acne Control Daily Moisturizer 20 mg/mL 82046-0617-01 | LOreal | 1 bottle | — | — | FDA listed | — |
| Curology Acne-Clearing Gel Serum 2 g/100mL 82575-0500-00 | Curology, | 1 tube | — | — | FDA listed | — |
| Good Molecules Maximum Strength Acne Gel Cream 2 g/100mL 82730-0102-01 | Good | 1 tube | — | — | FDA listed | — |
| Starface Acne Spot Treatment 20 mg/mL 83171-0003-01 | Starface | 1 tube | — | — | FDA listed | — |
| Dermacleanse Acne Spot Treatment .02 g/mL 83313-0062-01 | ZENMED | 30 ml | — | — | FDA listed | — |
| Skinkure Acne Eraser Spot Treatment 20 mg/mL 83865-0100-10 | SKINKURE, | 30 ml | — | — | FDA listed | — |
| Tula Skincare Clear It Up Acne Clearing and Tone Correcting Gel 2 g/100mL 84126-0121-15 | The | 1 tube | — | — | FDA listed | — |
| SEYTU Spot 2 g/100mL 84271-0002-00 | Omnilife | 1 tube | — | — | FDA listed | — |
| Perricone MD Acne Relief Maximum Strength Spot Gel 2 g/100g 84448-0538-14 | THG | 1 tube | — | — | FDA listed | — |
| Nativae Milia Acne Serum 20 mg/mL 85065-0557-00 | CDE | 30 ml | — | — | FDA listed | — |
| TRSTAY LUXE Clarifying Acne Repair Serum .02 g/mL 85277-0001-01 | Guangdong | 1 bottle | — | — | FDA listed | — |
| Duolaq 20 mg/mL 87110-0001-01 | METHODIQ | 1 bottle | — | — | FDA listed | — |
| HerbaGlow Baiwooxia Anti-Acne Gel 2 g/100g 87351-0087-01 | Kungpo | 1 jar | — | — | FDA listed | — |
| The Acne Spot Treatment 2 g/100g 87415-0100-04 | Spotless, | 1 tube | — | — | FDA listed | — |
| Acne Treatment 2 g/100mLthis 87799-0999-10 | Bio | 30 ml | — | — | FDA listed | — |
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.
⏳ Availability & generic status
🏛️
2026
On the market since
Feb 2026
📍
2026
Currently FDA-listed
listed with the FDA
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found
We did not find an FDA-approved generic match for this exact strength, form and route.
Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.
🔬 Reported adverse events (FAERS)
Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for Acne Treatment (this brand).
Top reported reactions
Reporter sex
Male · 38%
Female · 61%
Unknown · 1%
Serious outcomes
Reports over time (by year) — tap or hover for the count & year
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.
📦 Packaging — all sizes for this product
| Package NDC | Description | Marketing start | Status |
|---|---|---|---|
| 87799-0999-10 You're viewing this | 30 mL in 1 TUBE (87799-999-10) | 2026-02-19 | Active |
| 87799-0999-11 | 52 mL in 1 TUBE (87799-999-11) | 2026-02-19 | Active |
You're viewing the smallest of 2 pack sizes for this product.
Pack size FAQ
What quantity is in NDC 87799-0999-10?
NDC 87799-0999-10 contains 30 mL — 30 ml in 1 tube.
What is the difference between NDC 87799-0999-10 and NDC 87799-0999-11?
Both are ACNE TREATMENT Treat 2 g/100mL Gel — the drug itself is identical. NDC 87799-0999-10 is the 30 mL package, while NDC 87799-0999-11 is the 52 ml package.
What NDC number is used to bill for this package of ACNE TREATMENT Treat 2 g/100mL Gel?
Bill NDC 87799-0999-10 — the 11-digit billing format is 87799099910. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.
🧭 About this NDC listing & data coverage
Over-the-counter (OTC) product
What data is (and isn’t) available for this NDC — tap to expand
| NDC identity (package / product / labeler codes) | ✓ Available |
| Labeler | ✓ Available |
| Product & package description | ✓ Available |
| Marketing category & status | ✓ Available |
| Active ingredient / dosage form / route | ✓ Available |
| FDA label (SPL via DailyMed) | ✓ Available |
| Package photos | ✓ Available |
| Inactive ingredients (structured) | — Not published for this NDC The labeler did not submit a structured excipient list, or no SPL is available. |
| NADAC pharmacy acquisition price (CMS) | — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey. |
| Orange Book / therapeutic-equivalence data | — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope. |
| HCPCS J-code billing crosswalk | — Not published for this NDC Most self-administered / retail products have no J-code — that is normal. |
| Medicaid utilization (CMS SDUD) | — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold. |
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.
Questions about this listing
Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Otc Monograph Drug". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The FDA registers it as 87799-999-10, which is what is printed on the packaging and shown on DailyMed. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero: 87799-0999-10, written without dashes as 87799099910. The Identity section at the top of this page lists every form of this code.
What do the three segments of this NDC mean?
In 87799-0999-10, the first segment (87799) is the labeler code FDA assigned to Bio Clarity LLC; the middle segment (0999) identifies this specific product — its ingredient, strength, and dosage form; and the last segment (10) identifies this exact package size and type. Together they name one specific package of one specific product.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by Bio Clarity LLC. Listing status can change — the directory data on this page refreshes weekly.
Does this product come in other package sizes?
Yes — the FDA directory lists 1 other package presentation of this same product, including 52 ml (87799-0999-11). Each has its own NDC and its own page — see the package list near the top of this page.
Who lists this product with the FDA?
Bio Clarity LLC is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
📄 FDA label — Drug Facts FDA SPL
The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage
⏱️ Dosage and Administration
⚠️ Warnings
🧪 Active Ingredient
🧪 Inactive Ingredients
🎯 Purpose
🎯 Indications and Usage ▾
Uses For the treatment of Acne
⏱️ Dosage and Administration ▾
Directions Clean the skin thoroughly before applying product. Use dime sizes amount. Cover the affected area with a thin layer one or two times daily. Excessive drying of the skin may occur. Start with one applicatin daily, then gradually increase to two times a day if needed or as directed by a physician. If bothersome dryness or peeling occurs, reduce application to once a day or every other day.
⚠️ Warnings ▾
Warnings For External Use Only When using this product: Skin irritation and dryness is more likely to occur if you use another topical acne medication at a time. If irritation occurs, only use one topical medication at a time. If eye contact occurs, flush thouroughly with water.
🧪 Active Ingredient ▾
Active Ingredients: Salicylic Acid 2%
🧪 Inactive Ingredients ▾
Inactive Ingredients Water, butylene glycol, glycerin, ethoxydiglycol, neopentyl glycol dicaprylate/dicaprate, lactic acid, sodium lactate, hyaluronic acid - sodium salt, oat kernel extract, squalane, bisabolol, panthenol, lauryl lactate, methyl glucose sesquistearate, ergothioneine, hydroxyethyl acrylate/sodium acryloyldimethyl taurate copolymer, phenoxyethanol, polysorbate 60, disodium edta, xanthan gum, carbomer, sodium hydroxide, potassium sorbate
🎯 Purpose ▾
Acne treatment
No label section mentions that — try another word, or open the full label on DailyMed below.
Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA.
Prefer the government’s original formatting? View this label on DailyMed ↗
For educational and professional reference only — not medical advice. Pricing reflects published
NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.